Citius Pharmaceutical, CTXR, Biotech Stock Review

Citius Pharma (CTXR) Now Our #1 Ranked Idea for 2020.

Citius Pharmaceuticals (CTXR) is hands down one of the most exciting long-term opportunities we have come across since we first launched the...
Citius Pharma, biotech stock review,

Citius Pharma (CTXR) Corporate Presentation (Jan 2020).

Presentation Updated. Related: Citius Pharma (CTXR) Now Our #1 Ranked Idea for 2020.
Mitesco, Biotech Stock Review

Medtech Incubator True Nature | Mitesco (TNTY) Adds Another Heavy Hitter to Board.

True Nature Holding, Inc. DBA Mitesco, Inc. Adds Distinguished Healthcare Executive to Board of Directors.
Julie R Smith, True Nature, Mitesco

True Nature|Mitesco President & COO, Julie Smith Interview.

Julie R. Smith is a seasoned senior executive...

True Nature|Mitesco (TNTY). Coverage Report Issued.

Record Volume and Gradually Rising Price Portends to Higher Prices in 2020 as True Nature Executes on Recently Announced Incubator Strategy.
steven boyd, biotech stock review

Armistice Capital Master Fund Ltd., and Citius Pharma (CTXR).

April 2019 Offering On April 1, 2019, Citius entered into securities purchase agreements with institutional investors and accredited investors...

Mass General Brigham to Invest $100 Million in Telehealth and Digital Tools.

The five-year project aims to support consumer-centered care and patient engagement technology use. PatientEngagementHIT.com "Project...
Mitesco, Biotech Stock Review

True Nature (TNTY), a Medtech Startup Incubator Pays Down Some Toxic Notes.

This is a Welcome Step in the Right Direction. ATLANTA, GA, Nov. 29, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE...
True Nature, Mitesco, Biotech Stock Review

Is True Nature (TNTY) $0.04, Nearing a Breakout?

After a Tough Year, a Series of Development Releases Appears to Have Halted True Natures Downtrend and Move to a Possible...
True Nature, Mitesco, Biotech Stock Review

True Nature’s (TNTY) CEO Larry Diamond on Wall Street Analyzer.

Larry Diamond Reveals Some of True Nature's Goals and Ambitions to Incubate Medical Related Startups to Benefit All Shareholders.

Latest article

Dyadic

Could Dyadic (DYAI) $5.75 Provide a Solution to Help Mass Produce Vaccines to Battle...

Dyadic has developed a biomanufacturing technology platform, nicknamed C1 which helps to speed the development, lower the manufacturing cost and potentially improve...

Corona Virus Stocks in the News (Bloomberg, Benzinga).

Aethlon Medical, Inc. (NASDAQ: AEMD) $2.40   Alpha Pro Tech, Ltd. (NYSE: APT) $6.00AstraZeneca plc (NYSE: AZN) $49BioCryst Pharmaceuticals, Inc.'s (NASDAQ: BCRX) $2.80  Cerus Corporation (NASDAQ: CERS) $4.50Cleveland BioLabs, Inc. (NASDAQ: CBLI) $1.32Co-Diagnostics Inc (NASDAQ: CODX) $1.88Lakeland...
Immunomedics, Biotech Stock Review

Biotech 5 Pack. 5 Biotech Stocks We Expect to Double in 2020.

Our First Newsletter of 2020, We Come out Swinging! Yes, you read it right. Five of our favorite...